Barton on cutting edge with digital medicine
By Robert Glatter, Forbes
In a first, Barton Health will implement a unique digital medicine offering for treating hypertension, one of the most common chronic medical conditions in the U.S.
Referred to as Proteus Discover, the digital medicine offering incorporates an ingestible sensor – activated upon contact with stomach acid–which provides the information needed for patients and their physicians to partner on their health. This could include information related to a patient’s vital signs and the exact time the digital medicine offering was taken.
Proteus Discover, which utilizes FDA-approved technology incorporating ingestible digital sensors developed by Proteus Digital Health, represents the first commercial use of such technology after the recent success of initial clinical trials evaluating efficacy and reproducibility of the innovative monitoring technology.